Is Repligen Corporation (RGEN) A Good Stock To Buy Now?

Is RGEN a good stock to buy? We came across a bullish thesis on Repligen Corporation on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on RGEN. Repligen Corporation’s share was trading at $136.44 as of June 30th. RGEN’s trailing and forward P/E were 149.86 and 68.97 respectively according to Yahoo Finance.

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing...